Key considerations in reimbursement decision-making for multiple sclerosis drugs in Australia

Yen Hoang Le Phan, Richard De Abreu Lourenco*, Marion Haas, Naomi van der Linden

*Corresponding author for this work

Research output: Contribution to journalArticleScientificpeer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Key considerations in reimbursement decision-making for multiple sclerosis drugs in Australia'. Together they form a unique fingerprint.

INIS

Medicine and Dentistry

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science